# Scientific Synthesis: CYP46A1 Overexpression Gene Therapy for Neurodegeneration
## Dimension Scores
| Dimension | Score | Rationale |
|-----------|-------|-----------|
| **Mechanistic Plausibility** | 0.78 | Solid biological foundation (CYP46A1 is the rate-limiting enzyme for brain cholesterol elimination), multiple interconnected pathways (lipid raft remodeling, LXR activation, SREBP signaling), but relies on unproven assumption that modest cholesterol reductions will meaningfully shift amyloid pathology |
| **Evidence Strength** | 0.70 | Promising mouse model data (APP/PS1 and 3xTg-AD showing 40-50% Aβ reduction, memory restoration), but no human clinical data, therapeutic window for 24-OHC incompletely defined, and linear cholesterol-to-Aβ relationship inadequately validated |
| **Novelty** | 0.58 | CYP46A1 biology is well-established; gene therapy approach adds delivery innovation but the core target mechanism has been studied for decades |
| **Feasibility** | 0.65 | AAV-mediated delivery is technically feasible but requires BBB-penetrating strategies, neuronal tropism optimization, and raises long-term safety concerns; no selective small-molecule activators identified |
| **Therapeutic Potential** | 0.78 | Addresses major unmet need (AD affects ~50 million globally), disease-modifying potential, multi-target mechanism offers possible synergy with existing approaches, but narrow therapeutic window and off-target effects remain concerns |
---
## Top 3 Cited Papers
| Paper | Citation | Relevance |
|-------|----------|-----------|
| Astrocyte-neuron combined targeting for CYP46A1 gene therapy in Huntington's disease | DOI:10.1186/s40478-025-02054-4 | Direct gene therapy proof-of-concept; demonstrates therapeutic window achievability |
| Cholesterol: Its
["PMID:20457766", "PMID:23974665", "PMID:25269924", "PMID:29885487", "DOI:10.1186/s40478-025-02054-4**", "PMID:20876131", "PMID:15755746", "DOI:10.1089/hum.2016.087", "DOI:10.1186/s40478-025-02054-4)", "DOI:10.1016/j.redox.2017.10.014)", "DOI:10.1089/hum.2016.087)", "DOI:10.1186/s40478-025-02054-4"]